National Healthcare (NHC) Loans and Notes Receivables (2016 - 2025)
National Healthcare (NHC) has disclosed Loans and Notes Receivables for 15 consecutive years, with $505000.0 as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Loans and Notes Receivables rose 3.7% year-over-year to $505000.0, compared with a TTM value of $505000.0 through Mar 2025, up 3.7%, and an annual FY2024 reading of $512000.0, up 1.79% over the prior year.
- Loans and Notes Receivables was $505000.0 for Q1 2025 at National Healthcare, down from $512000.0 in the prior quarter.
- Across five years, Loans and Notes Receivables topped out at $8.8 million in Q1 2021 and bottomed at $302000.0 in Q4 2022.
- Average Loans and Notes Receivables over 5 years is $1.3 million, with a median of $512000.0 recorded in 2024.
- Peak annual rise in Loans and Notes Receivables hit 393.22% in 2021, while the deepest fall reached 51.19% in 2021.
- Year by year, Loans and Notes Receivables stood at $453000.0 in 2021, then tumbled by 33.33% to $302000.0 in 2022, then surged by 66.56% to $503000.0 in 2023, then increased by 1.79% to $512000.0 in 2024, then decreased by 1.37% to $505000.0 in 2025.
- Business Quant data shows Loans and Notes Receivables for NHC at $505000.0 in Q1 2025, $512000.0 in Q4 2024, and $578000.0 in Q3 2024.